PRP Versus HA IN OSTEOARTHRITIS OF THE PATELLOFEMORAL JOINT

Recruiting N/A Interventional Study
Patellofemoral Osteoarthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
30 – 65
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
166 (estimated)
Sponsor
Istituto Ortopedico Rizzoli · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of the study is to compare the 12-month clinical outcomes of patients with patellofemoral osteoarthritis undergoing infiltrative treatment with fresh PRP and HA

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age between 30 and 65; 2. Signs and symptoms of isolated patellofemoral osteoarthritis present in one or both knees; 3. Radiographic signs of isolated patellofemoral osteoarthritis (according to Iwano et al stage 1-3 classification) or chondropathy (assessed on MRI) with K-L …
Contacts

Roberta Licciardi, MSc

0516366567

roberta.licciardi@ior.it

CONTACT

Alessandro Di Martino, MD

alessandro.dimartino@ior.it

CONTACT